Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ferme

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nouvelle Revue Francaise D'Hematologie|August 1, 1993
Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scanP Brice, J D Rain, J Frija, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's diseaseP Brice, J Tredaniel, J J Monsuez, et al.
Presse Medicale (Paris, France : 1983)|July 14, 1984
[Hodgkin's disease. Residual histologically stable masses after chemotherapy]E Lepage, C Ferme, J Frija, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patientsP Andrivet, A Bacquer, C V Ngoc, et al.
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Leukemia & Lymphoma|July 16, 2005
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationE Jabbour, N Peslin, P Arnaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
British Journal of Cancer|May 18, 2001
Hodgkins diseaseC Ferme, J M Cosset, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2P Morel, P Gaulard, C Gisselbrecht, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nouvelle Revue Francaise D'Hematologie|August 1, 1993
Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scanP Brice, J D Rain, J Frija, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favorable Hodgkin's diseaseP Brice, J Tredaniel, J J Monsuez, et al.
Presse Medicale (Paris, France : 1983)|July 14, 1984
[Hodgkin's disease. Residual histologically stable masses after chemotherapy]E Lepage, C Ferme, J Frija, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1994
Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patientsP Andrivet, A Bacquer, C V Ngoc, et al.
The European Respiratory Journal|February 1, 1992
The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomasJ Tredaniel, P Brice, E Lepage, et al.
Leukemia & Lymphoma|July 16, 2005
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationE Jabbour, N Peslin, P Arnaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
British Journal of Cancer|May 18, 2001
Hodgkins diseaseC Ferme, J M Cosset, B Fervers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2007
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2P Morel, P Gaulard, C Gisselbrecht, et al.
Pageof 3